Elekta and IBA enter an MOU regarding a comprehensive partnership including joint software development and sales to advance proton therapy treatments
SAN DIEGO, September 23, 2017 – Elekta (EKTA-B.ST) and Ion Beam Applications (IBA) announced today that they have entered a Memorandum of Understanding (MOU) to agree to work closely together in software development as well as the sales and marketing of each other’s products. The announcement was made at the occasion of the American Society for Radiation Oncology (ASTRO) Annual Meeting, which is taking place September 24-27 in San Diego. The companies intend to co-invest in developing new functionality for proton therapy treatment in Elekta’s Monaco®